CabaƱog, Edna L.
HRN: 26-90-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/04/2025
04/10/2025
IVTT
600mg
Q6
Lung Abscess
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes